|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ledgerwood LG, Kumar D, Eterovic AK, Wick
J, Chen K, Zhao H, Tazi L, Manna P, Kerley S, Joshi R, et al: The
degree of intratumor mutational heterogeneity varies by primary
tumor sub-site. Oncotarget. 7:27185–27198. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ye H, Yu T, Temam S, Ziober BL, Wang J,
Schwartz JL, Mao L, Wong DT and Zhou X: Transcriptomic dissection
of tongue squamous cell carcinoma. BMC Genomics. 9:692008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Döbrossy L: Epidemiology of head and neck
cancer: Magnitude of the problem. Cancer Metastasis Rev. 24:9–17.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tímár J, Csuka O, Remenár E, Répássy G and
Kásler M: Progression of head and neck squamous cell cancer. Cancer
Metastasis Rev. 24:107–127. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stransky N, Egloff AM, Tward AD, Kostic
AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C,
McKenna A, et al: The mutational landscape of head and neck
squamous cell carcinoma. Science. 333:1157–1160. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Patel SC, Carpenter WR, Tyree S, Couch ME,
Weissler M, Hackman T, Hayes DN, Shores C and Chera BS: Increasing
incidence of oral tongue squamous cell carcinoma in young white
women, age 18 to 44 years. J Clin Oncol. 29:1488–1494. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ng JH, Iyer NG, Tan MH and Edgren G:
Changing epidemiology of oral squamous cell carcinoma of the
tongue: A global study. Head Neck. 39:297–304. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bello IO, Soini Y and Salo T: Prognostic
evaluation of oral tongue cancer: Means, markers and perspectives
(I). Oral Oncol. 46:630–635. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Almangush A, Heikkinen I, Mäkitie AA,
Coletta RD, Läärä E, Leivo I and Salo T: Prognostic biomarkers for
oral tongue squamous cell carcinoma: A systematic review and
meta-analysis. Br J Cancer. 117:856–866. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van Dijk BA, Brands MT, Geurts SM, Merkx
MA and Roodenburg JL: Trends in oral cavity cancer incidence,
mortality, survival and treatment in the Netherlands. Int J Cancer.
139:574–583. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thangaraj SV, Shyamsundar V, Krishnamurthy
A, Ramani P, Ganesan K, Muthuswami M and Ramshankar V: Molecular
portrait of oral tongue squamous cell carcinoma shown by
integrative meta-analysis of expression profiles with validations.
PLoS One. 11:e01565822016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ding X, Zhang N, Cai Y, Li S, Zheng C, Jin
Y, Yu T, Wang A and Zhou X: Down-regulation of tumor suppressor
MTUS1/ATIP is associated with enhanced proliferation, poor
differentiation and poor prognosis in oral tongue squamous cell
carcinoma. Mol Oncol. 6:73–80. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eslami A, Miyaguchi K, Mogushi K, Watanabe
H, Okada N, Shibuya H, Mizushima H, Miura M and Tanaka H: PARVB
overexpression increases cell migration capability and defines high
risk for endophytic growth and metastasis in tongue squamous cell
carcinoma. Br J Cancer. 112:338–344. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao T, Ding X, Chang B, Zhou X and Wang
A: MTUS1/ATIP3a down- regulation is associated with enhanced
migration, invasion and poor prognosis in salivary adenoid cystic
carcinoma. BMC Cancer. 15:2032015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rogler A, Hoja S, Giedl J, Ekici AB, Wach
S, Taubert H, Goebell PJ, Wullich B, Stöckle M, Lehmann J, et al:
Loss of MTUS1/ATIP expression is associated with adverse outcome in
advanced bladder carcinomas: Data from a retrospective study. BMC
Cancer. 14:2142014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bravou V, Antonacopoulou A, Papanikolaou
S, Nikou S, Lilis I, Giannopoulou E and Kalofonos HP: Focal
adhesion proteins α- and β-parvin are overexpressed in human
colorectal cancer and correlate with tumor progression. Cancer
Invest. 33:387–397. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qiu Z, Sun W, Gao S, Zhou H, Tan W, Cao M
and Huang W: A 16-gene signature predicting prognosis of patients
with oral tongue squamous cell carcinoma. PeerJ. 5:e40622017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bullinger L, Döhner K, Bair E, Fröhling S,
Schlenk RF, Tibshirani R, Döhner H and Pollack JR: Use of
gene-expression profiling to identify prognostic subclasses in
adult acute myeloid leukemia. N Engl J Med. 350:1605–1616. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Valk PJ, Verhaak RG, Beijen MA, Erpelinck
CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM,
Beverloo HB, Moorhouse MJ, van der Spek PJ, Löwenberg B and Delwel
R: Prognostically useful gene-expression profiles in acute myeloid
leukemia. N Engl J Med. 350:1617–1628. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vogelstein B, Papadopoulos N, Velculescu
VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes.
Science. 339:1546–1558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Estilo CL, O-charoenrat P, Talbot S, Socci
ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y,
Boyle JO, et al: Oral tongue cancer gene expression profiling:
Identification of novel potential prognosticators by
oligonucleotide microarray analysis. BMC Cancer. 9:112009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reis PP, Waldron L, Perez-Ordonez B,
Pintilie M, Galloni NN, Xuan Y, Cervigne NK, Warner GC, Makitie AA,
Simpson C, et al: A gene signature in histologically normal
surgical margins is predictive of oral carcinoma recurrence. BMC
Cancer. 11:4372011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krishnan NM, Dhas K, Nair J, Palve V,
Bagwan J, Siddappa G, Suresh A, Kekatpure VD, Kuriakose MA and
Panda B: A minimal DNA methylation signature in oral tongue
squamous cell carcinoma links altered methylation with tumor
attributes. Mol Cancer Res. 14:805–819. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Clough E and Barrett T: The gene
expression omnibus database. Methods Mol Biol. 1418:93–110. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Davis S and Meltzer PS: GEOquery: A bridge
between the Gene Expression Omnibus (GEO) and BioConductor.
Bioinformatics. 23:1846–1847. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mandel-Brehm C, Retallack H, Knudsen GM,
Yamana A, Hajj-Ali RA, Calabrese LH, Tihan T, Sample HA, Zorn KC,
Gorman MP, et al: Exploratory proteomic analysis implicates the
alternative complement cascade in primary CNS vasculitis.
Neurology. 93:e433–e444. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu Y, Qiu P and Ji Y: TCGA-assembler:
Open-source software for retrieving and processing TCGA data. Nat
Methods. 11:599–600. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Doecke JD, Chekouo TT, Stingo F and Do KA:
miRNA target gene identification: Sourcing miRNA target gene
relationships for the analyses of TCGA illumina MiSeq and RNA-Seq
Hiseq platform data. Int J Hum Genet. 14:17–22. 2017. View Article : Google Scholar
|
|
33
|
Chen WJ, Tang RX, He RQ, Li DY, Liang L,
Zeng JH, Hu XH, Ma J, Li SK and Chen G: Clinical roles of the
aberrantly expressed lncRNAs in lung squamous cell carcinoma: A
studybased on RNA-sequencing and microarray data mining.
Oncotarget. 8:61282–61304. 2017.PubMed/NCBI
|
|
34
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Amit M, Tam S, Takahashi H, Choi KY,
Zafereo M, Bell D and Weber RS: Prognostic performance of the
American Joint Committee on Cancer 8th edition of the TNM staging
system in patients with early oral tongue cancer. Head Neck.
41:1270–1276. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cancer Genome Atlas Network, .
Comprehensive genomic characterization of head and neck squamous
cell carcinomas. Nature. 517:576–582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ashley EA: The precision medicine
initiative: A new national effort. JAMA. 313:2119–2120. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pitiyage G, Tilakaratne WM, Tavassoli M
and Warnakulasuriya S: Molecular markers in oral epithelial
dysplasia: Review. J Oral Pathol Med. 38:737–752. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Duffy MJ: Use of biomarkers in screening
for cancer. Adv Exp Med Biol. 867:27–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kerkelä E and Saarialho-Kere U: Matrix
metalloproteinases in tumor progression: Focus on basal and
squamous cell skin cancer. Exp Dermatol. 12:109–125. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Stamenkovic I: Matrix metalloproteinases
in tumor invasion and metastasis. Semin Cancer Biol. 10:415–433.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li H, Zhong A, Li S, Meng X, Wang X, Xu F
and Lai M: The integrated pathway of TGFβ/Snail with TNFα/NFκB may
facilitate the tumor-stroma interaction in the EMT process and
colorectal cancer prognosis. Sci Rep. 7:49152017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shen CJ, Kuo YL, Chen CC, Chen MJ and
Cheng YM: MMP1 expression is activated by Slug and enhances
multi-drug resistance (MDR) in breast cancer. PLoS One.
12:e01744872017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lu X, Wang Q, Hu G, Van Poznak C, Fleisher
M, Reiss M, Massagué J and Kang Y: ADAMTS1 and MMP1 proteolytically
engage EGF-like ligands in an osteolytic signaling cascade for bone
metastasis. Genes Dev. 23:1882–1894. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mehner C, Miller E, Nassar A, Bamlet WR,
Radisky ES and Radisky DC: Tumor cell expression of MMP3 as a
prognostic factor for poor survival in pancreatic, pulmonary, and
mammary carcinoma. Genes Cancer. 6:480–489. 2015.PubMed/NCBI
|
|
48
|
Mariya T, Hirohashi Y, Torigoe T, Tabuchi
Y, Asano T, Saijo H, Kuroda T, Yasuda K, Mizuuchi M, Saito T and
Sato N: Matrix metalloproteinase-10 regulates stemness of ovarian
cancer stem-like cells by activation of canonical Wnt signaling and
can be a target of chemotherapy-resistant ovarian cancer.
Oncotarget. 7:26806–26822. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chung IC, Chen LC, Chung AK, Chao M, Huang
HY, Hsueh C, Tsang NM, Chang KP, Liang Y, Li HP and Chang YS:
Matrix metalloproteinase 12 is induced by heterogeneous nuclear
ribonucleoprotein K and promotes migration and invasion in
nasopharyngeal carcinoma. BMC Cancer. 14:3482014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Koshikawa N, Moriyama K, Takamura H,
Mizushima H, Nagashima Y, Yanoma S and Miyazaki K: Overexpression
of laminin gamma 2 chain monomer in invading gastric carcinoma
cells. Cancer Res. 59:5596–5601. 1999.PubMed/NCBI
|
|
51
|
Pyke C, Salo S, Ralfkiaer E, Rømer J, Danø
K and Tryggvason K: Laminin-5 is a marker of invading cancer cells
in some human carcinomas and is coexpressed with the receptor for
urokinase plasminogen activator in budding cancer cells in colon
adenocarcinomas. Cancer Res. 55:4132–4139. 1995.PubMed/NCBI
|
|
52
|
Kagesato Y, Mizushima H, Koshikawa N,
Kitamura H, Hayashi H, Ogawa N, Tsukuda M and Miyazaki K: Sole
expression of laminin gamma 2 chain in invading tumor cells and its
association with stromal fibrosis in lung adenocarcinomas. Jpn J
Cancer Res. 92:184–192. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hlubek F, Jung A, Kotzor N, Kirchner T and
Brabletz T: Expression of the invasion factor laminin gamma2 in
colorectal carcinomas is regulated by beta-catenin. Cancer Res.
61:8089–8093. 2001.PubMed/NCBI
|
|
54
|
Sordat I, Bosman FT, Dorta G, Rousselle P,
Aberdam D, Blum AL and Sordat B: Differential expression of
laminin-5 subunits and integrin receptors in human colorectal
neoplasia. J Pathol. 185:44–52. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Soini Y, Määttä M, Salo S, Tryggvason K
and Autio-Harmainen H: Expression of the laminin gamma 2 chain in
pancreatic adenocarcinoma. J Pathol. 180:290–294. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Takahashi S, Hasebe T, Oda T, Sasaki S,
Kinoshita T, Konishi M, Ochiai T and Ochiai A: Cytoplasmic
expression of laminin gamma2 chain correlates with postoperative
hepatic metastasis and poor prognosis in patients with pancreatic
ductal adenocarcinoma. Cancer. 94:1894–1901. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yamamoto H, Itoh F, Iku S, Hosokawa M and
Imai K: Expression of the gamma(2) chain of laminin-5 at the
invasive front is associated with recurrence and poor prognosis in
human esophageal squamous cell carcinoma. Clin Cancer Res.
7:896–900. 2001.PubMed/NCBI
|
